Market Overview:

The Breast Biopsy Devices Market size is estimated to reach $3.4 Billion by 2030, growing at a CAGR of 5.1% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Breast Biopsy Devices Market – By Product (Needle-Based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Devices, Vacuum-Assisted Biopsy Devices), Procedure Trays, Localization Wires, Others), By Guidance Technique (Ultrasound-Guided, Stereotactic-Guided, MRI-Guided, CT-Guided, Others), By End-User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), By Type (Open Surgical Breast Biopsy Devices, Needle Breast Biopsy Devices), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”
Rising demand for minimally invasive procedures and Expansion in emerging markets are expected to create growth opportunities in the market during forecast period.

North America Dominated the Market in 2023:

North America accounted for the largest share of 40% of the Breast Biopsy Devices Market in 2023 followed by Europe and APAC. Growing awareness among people regarding early diagnosis and government initiatives are further contributing to its market growth. Moreover, according to U.S. Department of Health and Human Services more than 1 million people have breast biopsies each year in the U.S. About 20% of these biopsies yield a diagnosis of breast cancer which is driving the overall demand for the market. 

Breast Biopsy Devices Market: Key Takeaways

Rise in Breast Cancer Screening Initiatives:

With global awareness efforts and government programs encouraging early detection of breast cancer, the demand for breast biopsy devices is on the rise. These initiatives aim to improve survival rates by diagnosing cancer at an earlier, more treatable stage, boosting the need for biopsy procedures and devices. As more hospitals and healthcare providers expand their screening capabilities, the market for breast biopsy devices is expected to grow significantly to meet this need.

Ultrasound Guided Biopsy is Poised to be the Fastest Growing:

As the demand for less painful, quicker procedures with higher accuracy rises, ultrasound guidance offers a non-invasive and real-time imaging solution, allowing for better targeting of abnormal tissue. This approach reduces procedure time and enhances patient recovery, making it increasingly popular among healthcare providers. With increasing healthcare investments, rising breast cancer awareness, and technological advancements in ultrasound systems, this segment is poised for continued rapid expansion. 

For More Queries About "Breast Biopsy Devices Market " @ https://www.industryarc.com/pdfdownload.php?id=504077

Scope of the Report: 

Report Metric

Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

5.1%

Market Size in 2030

$3.4 Billion

Segments Covered

By Product, By Guidance Technique, By End-User, By Type

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and the Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

1.  Argon Medical Devices, Inc.

2.  Becton, Dickinson and Company

3.  GE Healthcare

4.  B. Braun

5.  Boston Scientific Corporation

6.  Hologic, Inc.

7.  Cardinal Health, Inc.

8.  Cook Group Incorporated

9.  Danaher Corporation (Mammotome)

10.  Fujifilm Holdings Corporation



Recent Developments:

• In May 2023, Argon Medical Devices launched the SuperCore Advantage, a new semi-automatic biopsy instrument for the U.S. market.
• In May 2022, Terumo India joined forces with Argon Medical to bring a wider range of medical solutions to the Indian market. By combining their strengths, they addressed the increasing need for advanced tools in biopsies, deep vein thrombosis treatments, and other procedures.
• In April 2023, GE Healthcare unveiled the bkActiv system, an advanced ultrasound imaging solution designed for surgical applications. This system empowers surgeons by providing real-time imaging and enhancing their decision-making during surgical procedures.

Breast Biopsy Devices Market: Competitive Landscape

Key companies profiled in the Breast Biopsy Devices Market are Argon Medical Devices, Inc., Becton, Dickinson and Company, GE Healthcare, B. Braun, Boston Scientific Corporation, Hologic, Inc., Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation (Mammotome), Fujifilm Holdings Corporation, and Others.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.


Contact Us:

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 518-282-4727